Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
| Id | http://purl.bioontology.org/ontology/NDFRT/N0000005903
http://purl.bioontology.org/ontology/NDFRT/N0000005903
|
|---|---|
| Preferred Name | Digoxin [Chemical/Ingredient] |
| Synonyms |
Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
Digoxin
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-
Digoxin
|
|---|---|
| prefLabel | Digoxin [Chemical/Ingredient]
|
| MESH DEFINITION | A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
|
| MESH DUI | D004077
|
| MESH UI | M0006386
|
| MeSH name | Digoxin
|
| type | |
| tui |
T109
T121
|
| notation | N0000005903
|
| Semantic type UMLS property | |
| NUI | N0000005903
|
| Ingredient of |
See more
See less
|
| cui | C0012265
|
| NDFRT kind | INGREDIENT_KIND
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |